Study results showed that antibodies are present in one-third of patients with oropharyngeal cancer
Researchers at the National Cancer Institute, in collaboration with the International Agency for Research on Cancer, discovered that the presence of human papillomavirus (HPV) antibodies may help to identify those patients with an increased risk of developing HPV-related cancer of the oropharynx and do so years prior to diagnosis of the disease.
Study results were published online in the Journal of Clinical Oncology.
Source: NCI Press Release.